Article By:
Don Dion
Tuesday, March 1, 2016 12:11 PM EDT
Based in Waltham, Massachusetts, Syndax Pharmaceuticals Inc. is a late-stage biopharmaceutical company that is developing therapeutics for cancer. SNDX set to price its Nasdaq IPO this Wed. night, 3.2.2016;